Abstract
The present invention is a composition and method for facilitating the internalization of a therapeutic agent into a cell. Specifically, the invention relates to the use of the extracellular domain of basigin-2, cyclophilin, or anti-basigin-2 antibody or antibody fragment as a delivery moiety for internalization of a therape.
| Original language | English (US) |
|---|---|
| U.S. patent number | 8007808 |
| State | Published - Aug 30 2011 |